AbbVie Inc.

Pharmaceuticals
United States
Executive 1Mr. Richard A. Gonzalez, Chairman; Chief Executive Officer | Chairman; Chief Executive Officer
Executive 2Dr. Michael Severino, M.D., Executive Vice President; Chief Scientific Officer | President;
Earnings Per Share Growth (%)-57.03%
Cost of Goods Sold (US$ Millions)$4,426
Current Liabilities (US$ Millions)$11,400
Total Assets (US$ Millions)$16,088
Long Term Debt (Millions)$10,565
Return on Equity39.49%
Revenue (US$ Millions)$19,960
Total Company Assets$27,547
Revenue Growth (%)6.23%
Net Income (US$ Millions)$1,774
Earnings Per Share (US$)$1.10
Total Equity (US$ Millions)$1,742
Profit Margin (%)8.89%
Debt To Equity Ratio (%)6.06%
Inventories (Millions)$1,124